Yuqi Cui Selected Research

Yuqi Cui Research Topics

Disease

10	Atherosclerosis 12/2023 - 01/2015
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2015
5	Ischemia 01/2023 - 06/2020
5	Hyperlipidemias (Hyperlipidemia) 08/2021 - 12/2014
4	Inflammation (Inflammations) 01/2023 - 05/2016
4	Coronary Artery Disease (Coronary Atherosclerosis) 02/2019 - 11/2015
3	Infections 01/2023 - 01/2020
3	Atherosclerotic Plaque (Atheroma) 08/2021 - 11/2015
2	Chronic Limb-Threatening Ischemia 05/2022 - 10/2021
2	Neoplasms (Cancer) 08/2019 - 10/2016
2	Myocardial Infarction 01/2018 - 01/2017
2	Acute Coronary Syndrome 12/2017 - 01/2017
2	Reperfusion Injury 01/2015 - 01/2015
1	autosomal recessive Candidiasis familial chronic mucocutaneous 01/2023
1	Diabetes Mellitus 05/2022
1	Insulin Resistance 05/2022
1	Body Weight (Weight, Body) 05/2022
1	Stroke (Strokes) 01/2022
1	Colitis 01/2022
1	Transient Ischemic Attack 01/2022
1	Hemorrhage 01/2022
1	Pericardial Effusion 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Atrial Fibrillation 01/2022
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Neoplasm Metastasis (Metastasis) 08/2019
1	Colorectal Neoplasms (Colorectal Cancer) 08/2019
1	Carotid Artery Diseases 12/2017
1	Death (Near-Death Experience) 01/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2015
1	Fibrosis (Cirrhosis) 12/2015
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2015
1	Brain Injuries (Brain Injury) 01/2015

Drug/Important Bio-Agent (IBA)

8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2015
7	Acetylcysteine (Siran)FDA LinkGeneric 12/2023 - 08/2020
5	Particulate MatterIBA 01/2023 - 12/2015
5	oxidized low density lipoproteinIBA 07/2022 - 01/2015
4	erucylphosphocholineIBA 07/2022 - 01/2015
3	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2023 - 01/2020
3	CytokinesIBA 07/2022 - 08/2021
2	AntioxidantsIBA 01/2022 - 10/2021
2	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2022 - 01/2020
2	GW 4869IBA 01/2022 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 02/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 02/2019 - 01/2015
2	Prion ProteinsIBA 01/2015 - 01/2015
1	Oxygen (Dioxygen)IBA 07/2022
1	Cysteine (L-Cysteine)FDA Link 07/2022
1	Insulin (Novolin)FDA Link 05/2022
1	Advanced Glycation End ProductsIBA 05/2022
1	Blood Glucose (Blood Sugar)IBA 05/2022
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	12- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA 01/2022
1	Virulence Factors (Pathogenicity Factors)IBA 01/2022
1	Coenzyme A (CoA)IBA 01/2022
1	LDL Receptors (LDL Receptor)IBA 01/2022
1	EnzymesIBA 10/2021
1	Glutathione (Reduced Glutathione)IBA 10/2021
1	LipidsIBA 08/2021
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 06/2020
1	Conditioned Culture MediaIBA 01/2020
1	jugloneIBA 08/2019
1	Macrophage Migration-Inhibitory FactorsIBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	Troponin IIBA 01/2018
1	MB Form Creatine KinaseIBA 01/2018
1	S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 12/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	Lipoprotein(a)IBA 01/2017
1	SolutionsIBA 10/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2015

Therapy/Procedure

4	Therapeutics 01/2023 - 12/2014
2	Ligation 01/2023 - 08/2020
1	Catheters 01/2022
1	Lasers (Laser) 08/2020
1	Aftercare (After-Treatment) 01/2018
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2017
1	Intravenous Administration 10/2016